Unknown

Dataset Information

0

Exendin-4 Exhibits Enhanced Anti-tumor Effects in Diabetic Mice.


ABSTRACT: Type 2 diabetes (T2D) is associated with increased risk of cancers. In this connection, we previously demonstrated the promoting effect of diabetes on HPV-associated carcinogenesis using a xenograft model in db/db diabetic mice. The underlying mechanism of this observation might be partly contributed by dysregulated immune response in diabetes. In this study, we hypothesized that the impaired anti-tumor immune response in diabetic status could be modulated by exendin-4, a glucagon-like protein receptor agonist which exhibits anti-diabetic effects. We inoculated 10-week old db/db mice with 2?×?107 CUP-1 cells (Human Papilloma Virus (HPV)-16 E7 transfected continuous cell line) subcutaneously underneath the scruff, and treated mice with high (30 nmol/kg) or low (10 nmol/kg) dose of exendin-4 for 13 days. Compared with control groups, exendin-4 suppressed subcutaneous tumor growth in a dose-dependent manner, accompanied by increased interferon (IFN)-? secreting CD8+ cytotoxic T lymphocyte (CTL)/Foxp3+ regulatory T cell (Treg) ratio as well as Th1 proinflammatory cytokines IFN-? and IL-2. Collectively, these findings suggested an anti-tumor effect of exendin-4 in diabetic conditions, which might be resulted from direct immunomodulation.

SUBMITTER: He L 

PROVIDER: S-EPMC5431757 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exendin-4 Exhibits Enhanced Anti-tumor Effects in Diabetic Mice.

He Lan L   Law Priscilla T Y PTY   Wong Chun Kwok CK   Chan Juliana C N JCN   Chan Paul K S PKS  

Scientific reports 20170511 1


Type 2 diabetes (T2D) is associated with increased risk of cancers. In this connection, we previously demonstrated the promoting effect of diabetes on HPV-associated carcinogenesis using a xenograft model in db/db diabetic mice. The underlying mechanism of this observation might be partly contributed by dysregulated immune response in diabetes. In this study, we hypothesized that the impaired anti-tumor immune response in diabetic status could be modulated by exendin-4, a glucagon-like protein r  ...[more]

Similar Datasets

| S-EPMC3161330 | biostudies-literature
| S-EPMC6284576 | biostudies-literature
| S-EPMC2275367 | biostudies-literature
| S-EPMC5641089 | biostudies-other
| S-EPMC5431828 | biostudies-literature
2017-06-09 | GSE94840 | GEO
| S-EPMC7277375 | biostudies-literature
| S-EPMC4173760 | biostudies-other
| S-EPMC3137845 | biostudies-literature
| S-EPMC7323701 | biostudies-literature